This article was reviewed and updated in March 2026 to reflect the latest research on GLP-1 medicines including Wegovy, Ozempic and Mounjaro.
Wegovy vs Ozempic vs Mounjaro: What’s the Difference?
Wegovy, Ozempic and Mounjaro are medicines from a group often referred to as GLP-1 treatments. They help regulate appetite, blood sugar and metabolism.
- Wegovy (semaglutide) – licensed for weight management
- Ozempic (semaglutide) – licensed for type 2 diabetes
- Mounjaro (tirzepatide) – a newer medicine that targets two hormone pathways
Although Wegovy and Ozempic contain the same active ingredient, they are prescribed for different conditions and at different doses. Meanwhile, Mounjaro works slightly differently and has generated strong interest because of its effects on both weight and metabolic health.
GLP-1 medicines are offering new hope — not just for weight loss and diabetes management, but also for heart health. Exciting new research suggests that these treatments could help protect the heart, even without major weight loss. That is a significant shift in how we think about these medicines, offering many people a broader pathway to better health beyond the number on the scales.
Many people are also searching for Wegovy vs Ozempic to understand the differences between these GLP-1 medicines and how they compare with newer treatments like Mounjaro.
As a pharmacist prescriber with expertise in GLP-1 medicines, I want to help you understand what this could mean for your health and how we can explore the most appropriate treatment options for your individual needs.
Quick Comparison: Wegovy vs Ozempic vs Mounjaro
| Medicine | Active Ingredient | Main Use |
|---|---|---|
| Wegovy | Semaglutide | Weight management |
| Ozempic | Semaglutide | Type 2 diabetes |
| Mounjaro | Tirzepatide | Diabetes and weight management |
When comparing Wegovy vs Ozempic, the key point is that both medicines contain semaglutide, but they are licensed for different purposes. If you are comparing Mounjaro vs Wegovy, the main difference is that Mounjaro acts on two hormone pathways rather than one.
What Are Wegovy and Mounjaro?
Let’s start with the basics.
- Wegovy is the brand name for semaglutide, a medication originally developed to treat type 2 diabetes.
- Mounjaro is the brand name for tirzepatide, which works in a similar way but targets two hormone pathways instead of one.
Both drugs are part of a group called GLP-1 receptor agonists, although tirzepatide also has additional GIP activity. They work by mimicking natural hormones in your body that help control blood sugar, reduce appetite and slow digestion, making you feel fuller for longer.
These effects help with weight loss. However, researchers are also finding that these medicines may have an important impact on heart health and broader metabolic wellbeing.
Wegovy and Heart Protection: What the SELECT Trial Found
A major clinical trial called SELECT looked at people who were overweight or obese and had existing heart disease, but did not have diabetes.
Those who took Wegovy (semaglutide) had a 20% lower risk of serious heart problems, including:
- heart attacks
- strokes
- cardiovascular-related deaths
Even more interestingly, this benefit was seen even in people who did not lose a large amount of weight.
This suggests that Wegovy may be doing more than helping people slim down. It may also be improving blood pressure, cholesterol and inflammation, all of which are closely linked to cardiovascular risk.
Mounjaro: The Popular Newcomer with Heart Benefits Too
Mounjaro (tirzepatide) has become increasingly popular, particularly in the United States, and it is now gaining momentum in the UK as well. While it was first licensed for type 2 diabetes, and later for weight loss in some settings, researchers are also seeing promising signs that it may support heart health.
In a recent study called SUMMIT, people with heart failure and obesity who took Mounjaro experienced:
- 38% reduction in risk of worsening heart failure or cardiovascular death
- better quality of life
- lower body weight and waist size
Although it is not yet licensed specifically for heart protection, this is encouraging data. Mounjaro may offer another way to support people with obesity-related heart conditions, whether or not weight loss is the main goal.
This also helps answer the question “does Mounjaro protect your heart?” The evidence is promising, but the medicine is not currently prescribed specifically for heart protection alone.
So How Do These Medicines Help the Heart?
Let’s break it down simply. Whether you are taking Wegovy or Mounjaro, these medicines seem to help the heart in several important ways:
- Better blood sugar control – even for some people without diabetes
- Lower blood pressure – easing strain on the heart
- Improved cholesterol – especially reduced LDL cholesterol
- Less inflammation – a hidden driver of many heart conditions
- Weight loss – which still helps, but is not the whole story
Together, these effects may lower the risk of heart attacks, strokes and heart failure, even if the scale does not change dramatically.
A Personalised Approach to Heart and Weight Health
This is where things get exciting — and personal.
As a qualified pharmacist prescriber, I can work with you to:
- assess your individual health risks
- help you understand your options with medicines such as Wegovy or Mounjaro
- create a treatment plan tailored to your goals, whether that is weight loss, heart protection, or both
You do not have to wait for a GP referral to start the conversation. I am here to support you with expert advice and a caring, personalised approach.
You may also find these related articles helpful if you are exploring wider metabolic health:
- PCOS weight loss: can Wegovy or Mounjaro help?
- GLP-1 nausea support and practical advice
- Weight management consultation
Is It Right for You?
These medicines are not for everyone, and they should always be prescribed and monitored by a professional. Here are some questions we can explore together:
- Do you have a history of heart disease or high blood pressure?
- Are you struggling with weight-related health problems?
- Have you tried lifestyle changes but need more support?
- Do you want to reduce your future risk of heart events?
If you answered yes to any of the above, it may be worth booking a consultation to talk through the safest and most effective options.
What’s Next in the Research?
Wegovy has already been approved for reducing heart risk in some people. Mounjaro may not be far behind.
Researchers are also looking at other uses for these medications, including:
- reducing the risk of kidney disease
- improving fatty liver disease
- managing conditions such as PCOS and sleep apnoea
As we learn more, these treatments may become key tools in preventing serious health conditions, not just managing them once they have happened.
Frequently Asked Questions
Is Wegovy the same as Ozempic?
No. Both medicines contain semaglutide, but Wegovy is licensed for weight management while Ozempic is licensed for type 2 diabetes.
What is the difference between Wegovy and Ozempic?
When looking at Wegovy vs Ozempic, both medicines contain semaglutide. However, Wegovy is licensed for weight management while Ozempic is used to treat type 2 diabetes.
Is Mounjaro better than Wegovy?
Clinical studies suggest Mounjaro may produce greater average weight loss in some people. However, the most appropriate treatment depends on your individual health history, goals and medical assessment.
Do GLP-1 medicines protect the heart?
Large clinical trials suggest that some GLP-1 medicines may reduce cardiovascular risk, particularly in people with obesity or diabetes. However, suitability and prescribing decisions should always be made with a qualified healthcare professional.
Final Thoughts: There’s More to Health Than a Number on the Scales
It is easy to focus on weight as the main sign of progress. However, the science is now showing that the real value of medicines such as Wegovy and Mounjaro may lie in what they do beneath the surface — for your heart, your circulation and your long-term health.
If you are curious about how these treatments could support your health goals, it is worth having a conversation — with your GP or with a specialist pharmacist prescriber.
Let’s find the best path forward — together.
Ready to Take Control of Your Heart and Weight Health?
Ali Sparkes is a UK award-winning pharmacist and qualified prescriber who has been helping clients achieve their weight and wellness goals since 1992. With a post-graduate diploma in wellness coaching, she brings together expert medical knowledge and a compassionate, whole-person approach to care.
If you are considering treatments such as Wegovy or Mounjaro, or simply want trusted guidance tailored to your health, Ali is here to support you.
Book a consultation today and start your personalised path to better health.
Written by
Ali Sparkes
Pharmacist Prescriber
The Health Dispensary, Neath
Ali has over 30 years of experience helping people improve their health through pharmacy care, nutrition and preventative medicine.
